Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ESPR | Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO | May 09, 2023 | Buy | $1.26 | 20,000 | 25,192 | 312,816 | May 10, 2023, 04:12 PM | |
ESPR | Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO | Mar 17, 2023 | Sale | $1.78 | 6,999 | 12,479 | 292,816 | Mar 20, 2023, 04:16 PM | |
ESPR | Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO | Mar 07, 2023 | Sale | $5.06 | 5,441 | 27,510 | 194,815 | Mar 08, 2023, 04:21 PM | |
ESPR | Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO | Sep 19, 2022 | Sale | $6.94 | 3,394 | 23,548 | 198,257 | Sep 20, 2022, 04:08 PM | |
ESPR | Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO | Aug 05, 2022 | Buy | $5.80 | 8,606 | 49,950 | 198,771 | Aug 08, 2022, 04:14 PM | |
ESPR | Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO | Jun 17, 2022 | Sale | $4.99 | 4,552 | 22,719 | 190,165 | Jun 21, 2022, 04:07 PM | |
ESPR | Esperion Therapeutics, Inc. | Koenig Sheldon L. | President and CEO | Mar 17, 2022 | Sale | $4.58 | 571 | 2,615 | 194,717 | Mar 18, 2022, 04:29 PM | |
PTLA | PORTOLA PHARMACEUTICALS INC | Koenig Sheldon L. | EVP, Chief Commercial Officer | Jun 18, 2020 | Option Exercise | $8.36 | 488 | 4,080 | 488 | Jul 02, 2020, 04:30 PM | |
PTLA | PORTOLA PHARMACEUTICALS INC | Koenig Sheldon L. | EVP, Chief Commercial Officer | Jul 02, 2020 | Option Exercise | $18.00 | 5,563 | 100,134 | 0 | Jul 02, 2020, 04:30 PM | |
PTLA | PORTOLA PHARMACEUTICALS INC | Koenig Sheldon L. | EVP, Chief Commercial Officer | Mar 02, 2020 | Option Exercise | $9.68 | 4,327 | 41,885 | 37,991 | Mar 03, 2020, 06:54 PM |